Mechanisms of indirect allorecognition in graft rejection: Class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo

Transplantation

Volumn 62, Issue 6, 1996, Pages 705-710

  Chen, Wanjun ^a   Murphy, Barbara ^a   Waaga, Ana Maria ^a   Willett, Theresa A ^a   Russell, Mary E ^b   Khoury, Samia J ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE CELL; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0029784452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609270-00001     Document Type: Article

References (35)

1. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
2. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
3. Fangmann J, Dalchau R, Sawyer GJ, Priestly CA, Fabre JW. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992; 22: 1525.
4. Benichou G, Takizawa AP, Olson AC, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
5. Shirwan H, Learner M, Wang HK, Makowka L, Cramer DV. Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
6. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allorecognition: recognition by in vivo primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
7. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. Indirect pathway of allorecognition: the occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59: 612.
8. Sherwood RA, Brent L, Rayfield LS. Presentation of alloantigens by host cells. Eur J Imunnol 1986; 16: 569.
9. Dalchau R, Fangmann J, Fabre JW. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur J Immunol 1992; 22: 669.
10. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
11. Auchincloss HJ, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
12. Lee RS, Grusby ML, Glimsher LH, Winn HJ, Auchincloss HJ. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
13. Benham AM, Sawyer GJ, Fabre JW. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995; 59: 1028.
14. Oluwole SF, Chowdhury NC, Jin M, Hardy MA. Induction of transplantation tolerance in rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation 1993; 56: 1523.
15. Oluwole SF, Jin M-X, Chowdhury NC, Ohajekwe OA. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Transplantation 1994; 58: 1077.
16. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II MHC allopeptides induces donor specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461.
17. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125.
18. Remuzzi G, Noris M, Benigni A, Imberti O, Sayegh MH, Perico N. Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts triggered by thymic recognition of histocompatibility allopeptides. J Exp Med 1994; 180: 1967.
19. Ohajekwe OA, Chowdhury NC, Fiedor P, Hardy MA, Oluwole SJ. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens. Transplantation 1995; 60: 1139.
20. Liu Z, Sun Y, Xi Y, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643.
21. Braun YM, McCormack A, Webb G, Batchelor RJ. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 117.
22. Liu Z, Braunstein NS, Suciu-Foca N. T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 1992; 148: 35.
23. Liu Z, Sun YK, Xi YP, et al. Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J Immunol 1993; 150: 3180.
24. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc Natl Acad Sci USA 1992; 89: 7762.
25. Khoury SJ, Gallon L, Chen W, et al. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 181: 357.
26. Smith L, Dwight H, Theofilopoulos A. Complexity and sequence identification of 24 rat Vβ genes. J Immunol 1991; 147: 375.
27. Shirwan H, Chi D, Makowka L, Cramer DV. Lymphocyte infiltrating rat cardiac allografts express a limited repertoire of T cell receptor Vβ genes. J Immunol 1993; 151: 5228.
28. Hancock WW, Khoury SJ, Carpenter CB, Sayegh MH. Differential effects of oral versus intrathymic administration of polymorphic MHC class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am J Pathol 1994; 144: 1149.
29. Lechler RI, Batchelor JR. Immunogenicity of retransplanted rat kidney allografts: effects of including chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med 1982; 156: 1835.
30. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
31. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221.
32. Deng Ping Y, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339.
33. Benham A, Fabre JW. Fine specificity of peptide determinants for indirect T cell recognition of class I MHC alloantigens. Transplantation 1994; 58: 1236.
34. Cher D, Mosmann T. Two types of murine helper T cell clones. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987; 138: 3688.
35. Wong R, Ruddle N, Padula S, et al. Subtypes of helper cells. Non-inflammatory type I helper T cells. J Immunol 1988; 141: 3329.